2024 ICD-10-CM Diagnosis Code D48.9
Neoplasm of uncertain behavior, unspecified
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoid tumor
- Extragonadal teratoma
- Fibromatosis colli
- Giant cell tumor
- Histologic features of tumor cannot be determined
- Histologic type of tumor-associated epithelial lesion cannot be determined
- Inflammatory myofibroblastic tumor
- Juvenile hemangioendothelioma
- Neoplastic disease of uncertain behavior
- Perivascular epithelioid cell neoplasm of uncertain behavior
Clinical Category is Neoplasms of unspecified nature or uncertain behavior
- CCSR Category Code: NEO072
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Apudomaa general term collectively applied to tumors associated with the apud cells series, irrespective of their specific identification.
Hypothalamic Neoplasmsbenign and malignant tumors of the hypothalamus. pilocytic astrocytomas and hamartomas are relatively frequent histologic types. neoplasms of the hypothalamus frequently originate from adjacent structures, including the optic chiasm, optic nerve (see optic nerve neoplasms), and pituitary gland (see pituitary neoplasms). relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (from devita et al., cancer: principles and practice of oncology, 5th ed, p2051)
Teratomaa true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. it is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. they are classified histologically as mature (benign) or immature (malignant). (from devita jr et al., cancer: principles & practice of oncology, 3d ed, p1642)
Hemangioendotheliomaa neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). they affect men and women about equally and rarely develop in childhood. (from stedman, 25th ed; holland et al., cancer medicine, 3d ed, p1866)
Hemangioendothelioma, Epithelioida tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. these tumors are thought to have "borderline" aggression, where one-third develop local recurrences, but only rarely metastasize. it is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to kimura's disease (see angiolymphoid hyperplasia with eosinophilia). (segen, dictionary of modern medicine, 1992)
Carcinoid Tumora usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. the tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. it is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (from stedman, 25th ed & holland et al., cancer medicine, 3d ed, p1182)
Gangliogliomarare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. they tend to occur in the optic nerve and white matter of the brain and spinal cord.
APUD Cellscells with the capacity to take up and decarboxylate the amine precursors dihydroxyphenylalanine or 5-hydroxytryptophan. this is a property of endocrine cells of neural and non-neural origin. apudoma is a general term collectively applied to tumors associated with apud cells.
Angiolymphoid Hyperplasia with Eosinophiliasolitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.
Childhood Giant Cell Tumor of Bone|Pediatric Giant Cell Tumor of Bonea giant cell tumor of bone that occurs during childhood.
Childhood Tenosynovial Giant Cell Tumor|Pediatric Tenosynovial Giant Cell Tumora tenosynovial giant cell tumor that occurs during childhood.
Giant Cell Tumora benign, intermediate, or malignant tumor that arises from the bone or soft tissue. it is characterized by the presence of multinucleated osteoclast-like giant cells.
Giant Cell Tumor of Bone|Benign Bone Giant Cell Tumor|GCTB|GIANT CELL TUMOR, BENIGN|Giant Cell Tumor of the Bone|Giant cell tumor of bone, NOS|Osteoclastoma|Osteoclastoma, Benigna benign but locally aggressive tumor that arises from the bone and is composed of mononuclear cells admixed with macrophages and osteoclast-like giant cells. it usually arises from the ends of long bones or the vertebrae. clinical presentation includes pain, edema, and decreased range of motion in the affected joint.
Giant Cell Tumor of Soft Tissue|GCT-ST|Giant Cell Tumor of Low Malignant Potential|Giant cell tumor of soft parts, NOS|Osteoclastoma of Soft Tissuea painless, well circumscribed tumor arising in soft tissue, usually of the upper and lower extremities. morphologically, it is characterized by a multinodular growth pattern. the cellular infiltrate is composed of mononuclear round or oval cells and multinucleated osteoclast-like giant cells, in a rich vascular stroma. it rarely metastasizes.
Malignancy in Giant Cell Tumor of Bone|Dedifferentiated Giant Cell Tumor|Dedifferentiated Giant Cell Tumor|Giant Cell Bone Sarcoma|Giant Cell Bone Sarcoma|Giant Cell Sarcoma of Bone|Giant Cell Sarcoma of Bone|Giant Cell Sarcoma of the Bone|Giant Cell Sarcoma of the Bone|Giant cell sarcoma of bone|Giant cell tumor of bone, malignant|Malignancy in Giant Cell Tumor of the Bone|Malignant Giant Cell Tumor of Bone|OSTEOCLASTOMA, MALIGNANTa malignant tumor that arises from the bone. it is characterized by the presence of an area of high grade sarcoma in an otherwise typical giant cell tumor (primary malignancy in giant cell tumor), or the presence of sarcoma in which the pre-existing giant cell tumor may or may not be apparent (secondary malignancy in giant cell tumor).
Malignant Giant Cell Neoplasm|GIANT CELL TUMOR, MALIGNANT|Malignant Giant Cell Tumor|Malignant Giant Cell Tumor|Malignant tumor, giant cell typea malignant neoplasm characterized by then presence of atypical giant cells.
Malignant Tenosynovial Giant Cell Tumor|Giant cell tumor of tendon sheath, malignant|Malignant Giant Cell Neoplasm of Tendon Sheath|Malignant Giant Cell Neoplasm of the Tendon Sheath|Malignant Giant Cell Tumor of Tendon Sheath|Malignant Giant Cell Tumor of the Tendon Sheath|Malignant Tendon Sheath Giant Cell Neoplasm|Malignant Tendon Sheath Giant Cell Tumor|Malignant tenosynovial giant cell tumoran uncommon malignant tumor arising from the tendon sheath. morphologically, it is characterized by the presence of a cellular infiltrate reminiscent of a giant cell tumor with prominent malignant characteristics. recurrent giant cell tumors with a sarcomatous dedifferentiation are included in this category as well.
Osteoblastoma|Giant Osteoid Osteoma|Giant Osteoid Osteoma|Giant osteoid osteoma|OSTEOBLASTOMA, BENIGN|Ossifying Giant Cell Tumor|Ossifying Giant Cell Tumor|Osteoblastoma, NOSa rare benign bone-forming neoplasm usually arising from the spine. it is a well-circumscribed lytic tumor that varies in size. the tumor is composed of woven bone trabeculae and shares similar histologic characteristics with the osteoid osteoma. surgical curettage is the treatment of choice. the prognosis is excellent.
Tenosynovial Giant Cell Tumor, Diffuse Type|Diffuse Giant Cell Neoplasm of Tendon Sheath|Diffuse Giant Cell Neoplasm of Tenosynovium|Diffuse Giant Cell Neoplasm of the Tenosynovium|Diffuse Giant Cell Tumor of Tendon Sheath|Diffuse Giant Cell Tumor of Tenosynovium|Diffuse Giant Cell Tumor of the Tenosynovium|Diffuse Tenosynovial Giant Cell Neoplasm|Diffuse Tenosynovial Giant Cell Tumor|Pigmented Villonodular Synovitisa locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath. it is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells. multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare. it predominantly affects young adults. symptoms include joint swelling, pain, and joint effusion.
Tenosynovial Giant Cell Tumor, Localized Type|Localized Giant Cell Neoplasm of Tendon Sheath|Localized Giant Cell Neoplasm of Tenosynovium|Localized Giant Cell Neoplasm of the Tenosynovium|Localized Giant Cell Tumor of Tendon Sheath|Localized Giant Cell Tumor of Tenosynovium|Localized Giant Cell Tumor of the Tenosynovium|Localized Tenosynovial Giant Cell Neoplasm|Localized Tenosynovial Giant Cell Tumor|Nodular Tenosynovitisa well-circumscribed, lobulated tumor, completely or partially covered by a fibrous capsule. it usually arises in the fingers. it is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. the tumor is slow-growing, usually developing over several years. clinical presentation includes painless edema of the affected site.
Tenosynovial Giant Cell Tumor|Fibrous Histiocytoma of Tendon Sheath|Fibrous histiocytoma of tendon sheath|Giant Cell Neoplasm of Tendon Sheath|Giant Cell Neoplasm of Tenosynovium|Giant Cell Neoplasm of the Tenosynovium|Giant Cell Tumor of Tendon Sheath|Giant Cell Tumor of Tenosynovium|Giant Cell Tumor of the Tenosynovium|Giant cell tumor of tendon sheath|Tendon Sheath Giant Cell Neoplasm|Tendon Sheath Giant Cell Tumor|Tenosynovial Giant Cell Neoplasm|Tenosynovial giant cell tumora tumor usually arising in the synovium of joints, bursa or tendon sheath. it is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. according to the growth pattern, it is classified as localized or diffuse.
Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells|Giant Cell Fibrous Histiocytoma|Giant Cell Malignant Fibrous Histiocytoma|Malignant Giant Cell Neoplasm of Soft Parts|Malignant Giant Cell Tumor of Soft Parts|Malignant giant cell tumor of soft partsan undifferentiated pleomorphic sarcoma characterized by the presence of osteoclast-like giant cells and cellular pleomorphism.
Childhood Extragonadal Teratomaan extragonadal teratoma that occurs during childhood.
Extragonadal Teratomaa teratoma that develops as a primary tumor in an anatomic site other than the testis or ovary.
Immature Extragonadal Teratomaan immature teratoma that develops as a primary tumor in an anatomic site other than the testis or ovary.
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
»unknown site or unspecified
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
 Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.